
Congenital Diarrhea 7 with Exudative Enteropathy: Unraveling the Genetic Puzzle
Chronic diarrhea with protein loss follows when intestinal epithelium genes are altered; DNA testing shortens the CD7EE diagnostic path that once leaned on biopsies.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Chronic diarrhea with protein loss follows when intestinal epithelium genes are altered; DNA testing shortens the CD7EE diagnostic path that once leaned on biopsies.

Jaundice, fatigue and an enlarged spleen follow the faulty red cell development in CDA 1B. Gene testing separates it from other anemias and informs transfusion decisions.

Small head size at birth, brain dysfunction with seizures and motor difficulty, and gradual loss of brain tissue define this syndrome that genome sequencing can trace.

An expansion of a non-coding repeat in TCF4 is the main genetic factor in Fuchs endothelial corneal dystrophy, usually starting in middle age with glare and blurring.

Premature fusion of cranial sutures can raise intracranial pressure and alter head shape, and testing is weighed as a guide to surgery timing and counseling.

More than one gene can produce DEE17, and variants of uncertain significance often leave results ambiguous, which complicates both diagnosis and treatment choices.

SCN1A mutations can act by loss or gain of function, and mosaicism affects severity, so testing for both shapes drug choice and family planning in DEE18.

Next-generation and whole exome sequencing separate DEE19 from similar encephalopathies, and the mutation found may point toward a ketogenic diet or particular drugs.